(I) TO PROVIDE FUNDING FOR RESEARCH AND APPLICATION OF STEM CELL TECHNIQUES, AUTOIMMUNE DISEASES AND NANOSCIENCE TECHNOLOGY; AND PATIENTS SEEKING TREATMENT OF SUCH DISEASES; AND(2) TO OPERATE EXCLUSIVELY FOR CHARITABLE, SCIENTIFIC, LITERARY, RELIGIOUS, OR EDUCATIONAL PURPOSES, WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986 (OR THE CORRESPONDING PROVISION OF ANY FUTURE UNITED STATES INTERNAL REVENUE LAW).